+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Heart Attack Diagnostics Market by Product Type (Biomarker Testing, Electrocardiography, Imaging), Technology (Laboratory Based, Point Of Care), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674421
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The heart attack diagnostics market is rapidly advancing as clinical care teams demand faster, more accurate tools for early detection and risk assessment. Senior leaders seeking to maintain a competitive edge must consider how innovation, regulation, and shifting global supply chains are shaping opportunities and challenges across the value chain.

Market Snapshot: Heart Attack Diagnostics Market Outlook

The heart attack diagnostics market grew from USD 14.96 billion in 2024 to USD 16.16 billion in 2025. It is expected to continue growing at a CAGR of 7.80%, reaching USD 23.49 billion by 2030. This expansion is powered by emerging biomarker assays, advanced imaging, and increased investments in rapid point of care technologies across healthcare environments.

Scope & Segmentation

This analysis delivers full visibility across the evolving heart attack diagnostics industry, covering products, technologies, end users, applications, and regions:

  • Product Types: Biomarker testing (CK-MB, Troponin I, Troponin T), Electrocardiography (resting and stress ECG), Imaging (computed tomography, magnetic resonance imaging)
  • Technologies: Laboratory-based platforms (high sensitivity troponin assays, immunoassays), Point of care solutions (handheld and portable devices)
  • End Users: Ambulatory care centers, Diagnostic centers, Home care, Hospitals
  • Applications: Acute detection, Risk assessment, Secondary prevention
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (noteworthy markets include United Kingdom, Germany, France, Russia, Italy, Spain, and others), Asia-Pacific (focusing on China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Featured Companies: F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, Sysmex Corporation, Koninklijke Philips N.V.

Primary Keyword: Heart Attack Diagnostics Market

Key Takeaways for Decision Makers

  • Adoption of high sensitivity assays is transforming clinical protocols, enabling rapid detection and more precise risk stratification in acute cardiac events.
  • Advanced imaging modalities, like computed tomography and magnetic resonance imaging, add value by improving anatomical and functional assessments for tailored treatment planning.
  • Point of care technologies are expanding diagnostics accessibility beyond the hospital, especially in remote and resource-limited settings, supporting more timely interventions.
  • Interdisciplinary collaboration across laboratory, emergency, and cardiology teams enhances pathway optimization for better patient outcomes.
  • Integration of digital health platforms and analytics tools is supporting real-time data sharing, pattern recognition, and operational efficiency across care networks.
  • Strategic partnerships and M&A activities are accelerating the development of comprehensive, end-to-end diagnostic solutions that align with evolving provider needs.

Assessing Tariff Impact: Supply Chains, Costs, and Access

Recent United States tariff adjustments have significantly influenced procurement, pricing strategies, and supply chain dynamics in cardiac diagnostics. Import duties on critical reagents and imaging hardware have led many manufacturers to explore dual sourcing and local manufacturing to manage rising costs and ensure reliability of supply. Health systems are responding by renegotiating contracts and evaluating value-based procurement to sustain access to essential diagnostic services despite external pressures.

Methodology & Data Sources

This report applies a robust methodology, integrating in-depth interviews with cardiology and laboratory experts alongside review of peer-reviewed journals, guidelines, and global device registries. Insights are triangulated to validate trends and provide a trustworthy foundation for business decisions.

Why This Report Matters

  • Enables informed strategic investments by detailing technology adoption patterns and region-specific dynamics in heart attack diagnostic solutions.
  • Provides actionable insights to navigate shifts in regulatory and supply chain environments, supporting resilient procurement and product planning.
  • Highlights collaboration opportunities among diagnostics providers, healthcare organizations, and regulators for innovation and market leadership.

Conclusion

The heart attack diagnostics market is defined by rapid innovation, growing regional diversity, and a shift toward more integrated, data-driven clinical pathways. Stakeholders that adapt to these realities are best positioned to drive operational and patient care improvements amid evolving global demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of high-sensitivity troponin assays for rapid and accurate myocardial infarction detection
5.2. Integration of artificial intelligence algorithms to predict heart attack risk from multimodal patient data
5.3. Expansion of portable point-of-care diagnostic devices enabling emergency troponin testing in rural settings
5.4. Implementation of remote patient monitoring platforms incorporating wearable ECG and biomarker tracking
5.5. Development of multiplex biomarker panels combining cardiac proteins and inflammatory markers for early diagnosis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Heart Attack Diagnostics Market, by Product Type
8.1. Introduction
8.2. Biomarker Testing
8.2.1. CK-MB
8.2.2. Troponin I
8.2.3. Troponin T
8.3. Electrocardiography
8.3.1. Resting ECG
8.3.2. Stress ECG
8.4. Imaging
8.4.1. Computed Tomography
8.4.2. Magnetic Resonance Imaging
9. Heart Attack Diagnostics Market, by Technology
9.1. Introduction
9.2. Laboratory Based
9.2.1. High Sensitivity Troponin Assay
9.2.2. Immunoassay
9.3. Point Of Care
9.3.1. Handheld Devices
9.3.2. Portable Devices
10. Heart Attack Diagnostics Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Diagnostic Centers
10.4. Home Care
10.5. Hospitals
11. Heart Attack Diagnostics Market, by Application
11.1. Introduction
11.2. Acute Detection
11.3. Risk Assessment
11.4. Secondary Prevention
12. Americas Heart Attack Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Heart Attack Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Heart Attack Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Siemens Healthineers AG
15.3.4. Danaher Corporation
15.3.5. QuidelOrtho Corporation
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. bioMérieux SA
15.3.8. Becton, Dickinson and Company
15.3.9. Sysmex Corporation
15.3.10. Koninklijke Philips N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEART ATTACK DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEART ATTACK DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. HEART ATTACK DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. HEART ATTACK DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. HEART ATTACK DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY CK-MB, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY CK-MB, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN I, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN I, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN T, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TROPONIN T, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RESTING ECG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RESTING ECG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STRESS ECG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STRESS ECG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HIGH SENSITIVITY TROPONIN ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HIGH SENSITIVITY TROPONIN ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ACUTE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ACUTE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY SECONDARY PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 116. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 117. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 118. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 119. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 120. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 121. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 124. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 125. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 126. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 127. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 226. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 227. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 228. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 231. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 234. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 235. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 244. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 245. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 246. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 247. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 248. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 249. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 252. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 253. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 280. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 281. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 282. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 283. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 284. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 285. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 286. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 287. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 288. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 289. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 290. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 291. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 298. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 299. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 300. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 301. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 302. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 303. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2024 (USD MILLION)
TABLE 306. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2025-2030 (USD MILLION)
TABLE 307. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, 2025-2030 (USD MILLION)
TABLE 309. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Heart Attack Diagnostics market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • Koninklijke Philips N.V.

Table Information